Evidence map›Paper›PMID 23022210›Full record

ArticleThe American journal of pathology2012

Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease.

Dolores Di Vizio, Matteo Morello, Andrew C Dudley, Peter W Schow, Rosalyn M Adam, Samantha Morley, David Mulholland, Mirja Rotinen, Martin H Hager, Luigi Insabato and 9 more

Open access · greenAbstract read
In one paragraph

Article in The American journal of pathology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 279 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
279citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

279 citing papers in PubMed, 2 syntheses or guidelines pooled it, 393 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Extracellular vesicles: Navigating new frontiers in glioblastoma therapy.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Extracellular vesicles inEXO : beyond the cell · 2026
    Article
  18. Review
  19. Review
  20. Article

219 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 1 country.

Dolores Di VizioDivision of Cancer Biology and Therapeutics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA. dolores.divizio@childrens.harvard.edu
Matteo Morello
Andrew C Dudley
Peter W Schow
Rosalyn M Adam
Samantha Morley
David Mulholland
Mirja Rotinen
Martin H Hager
Luigi Insabato
Marsha A Moses
Francesca Demichelis
Michael P Lisanti
Hong Wu
Michael Klagsbrun
Neil A Bhowmick
Mark A Rubin
Crislyn D'Souza-Schorey
Michael R Freeman
Boston Children's Hospital · USCedars-Sinai Medical Center · USCornell University · USHarvard University · USUniversity of California, Los Angeles · USSidney Kimmel Cancer Center · USUniversity of Notre Dame · US

Funding

Targeting the vasculature to enhance anti-tumor immunityR01CA177875 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Andrew Carl Dudley · 2014 to 2026
$4.5M
TGFB Signals in Prostate Stromal-Epithelial InteractionsR01CA108646 · NCI · VANDERBILT UNIVERSITY · PI BHOWMICK, NEIL A. · 2004 to 2016
$2.9M
Cholesterol and Prostate HealthR01DK087806 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI FREEMAN, MICHAEL R · 2011 to 2015
$1.9M
Amoeboid Membrane Dynamics in Prostate CancerR01CA143777 · NCI · CEDARS-SINAI MEDICAL CENTER · PI FREEMAN, MICHAEL R · 2010 to 2014
$1.7M
Molecular Mechanisms of Cell InvasionR01CA115316 · NCI · UNIVERSITY OF NOTRE DAME · PI D'SOUZA-SCHOREY, CRISLYN · 2011 to 2016
$1.5M
CELL SIGNALING IN BLADDER HYPERTROPHYR01DK057691 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI FREEMAN, MICHAEL R · 2000 to 2004
$1.2M
Tumor endothelial cell abnormalitiesR00CA140708 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUDLEY, ANDREW CARL · 2011 to 2013
$732k
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate CancerR00CA131472 · NCI · CEDARS-SINAI MEDICAL CENTER · PI DI VIZIO, DOLORES · 2010 to 2012
$722k
Fatty Acid Synthase, Caveolin-1 and Membrane Microdomains in Prostate CancerK99CA131472 · NCI · BOSTON CHILDREN'S HOSPITAL · PI DI VIZIO, DOLORES · 2008 to 2009
$273k
BLRD VA I01 BX001040NCI NIH HHS K99 CA131472NCI NIH HHS K99CA131472NCI NIH HHS R00 CA131472NCI NIH HHS R00 CA140708NCI NIH HHS R01 CA108646NCI NIH HHS R01 CA115316NCI NIH HHS R01 CA143777NCI NIH HHS R01CA143777NCI NIH HHS R01 CA177875NIDDK NIH HHS R01 DK057691NIDDK NIH HHS R01 DK087806NIDDK NIH HHS R01DK57691
6 · The paper itself

Abstract

Oncosomes are tumor-derived microvesicles that transmit signaling complexes between cell and tissue compartments. Herein, we show that amoeboid tumor cells export large (1- to 10-μm diameter) vesicles, derived from bulky cellular protrusions, that contain metalloproteinases, RNA, caveolin-1, and the GTPase ADP-ribosylation factor 6, and are biologically active toward tumor cells, endothelial cells, and fibroblasts. We describe methods by which large oncosomes can be selectively sorted by flow cytometry and analyzed independently of vesicles <1 μm. Structures resembling large oncosomes were identified in the circulation of different mouse models of prostate cancer, and their abundance correlated with tumor progression. Similar large vesicles were also identified in human tumor tissues, but they were not detected in the benign compartment. They were more abundant in metastases. Our results suggest that tumor microvesicles substantially larger than exosome-sized particles can be visualized and quantified in tissues and in the circulation, and isolated and characterized using clinically adaptable methods. These findings also suggest a mechanism by which migrating tumor cells condition the tumor microenvironment and distant sites, thereby potentiating advanced disease.

Indexed as

ADP-Ribosylation Factor 6AnimalsCaveolin 1Cell-Derived MicroparticlesCell Line, TumorFlow CytometryHumansMaleMiceModels, BiologicalNeoplasm InvasivenessNeoplasm MetastasisProstatic NeoplasmsADP-Ribosylation Factor 6ARF6 protein, humanArf6 protein, mouseCaveolin 1

Identifiers

PMID23022210
PMCPMC3483805
OpenAlexW1982669563

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.